来自MSN6 个月
Aura Stock Up as Lead Drug Shows Superior Efficacy in Eye Cancer Study
Shares of Aura Biosciences AURA gained 7.9% on Sept ... a layer of blood vessels and connective tissue between the sclera (white of the eye) and retina. It is the most common primary intraocular ...
pharmaphorum4 年
Aura raises $80m to develop its virus-like cancer drugs
US biotech Aura Biosciences has closed an oversubscribed financing, raising $80 million to help take its lead virus-like drug conjugate (VDC) for a cancer that affects the eye into late-stage ...